Tablet
Approved Tablet Formulations
| S.No. | Generic Name & Dosage Form | Composition |
|---|---|---|
| 1. | Clopidogrel & Aspirin Tablets IP | Each film coated bilayered tablet contains : Clopidogrel Bisulphate IP Equivalent To Clopidogrel 75 mg Aspirin IP 75 mg Excipients q.s Colour : Red Oxide Of Iron and Titanium Dioxide IP |
| 2. | Atorvastatin & Fenofibrate Tablets IP | Each film coated tablet contains: Atorvastatin Calcium IP Equivalent to Atorvastatin 10 mg Fenofibrate IP 160 mg Excipients q.s Colour : Ferric Oxide Red USP NF, Titanium Dioxide IP |
| 3. | Metoprolol Succinate Extended Release & Ramipril Tablets | Each uncoated bilayered tablet contains: Metoprolol Succinate IP Equivalent to Metoprolol Tartrate 25 mg (As Extended Release) Ramipril IP 5 mg Excipients q.s Colour : Sunset Yellow |
| 4. | Mycophenolate Mofetil Tablets IP 500 mg | Each film coated tablet contains: Mycophenolate Mofetil IP 500 mg Excipients q.s Colour : Ferric Oxide Red USP NF, Titanium Dioxide IP |
| 5. | Fenofibrate Tablets IP 160 mg | Each film coated tablet contains: Fenofibrate IP 160 mg Excipients q.s Colour: Red Oxide of Iron and Titanium Dioxide IP |
| 6. | Eplerenone Tablets IP 50 mg | Each film coated tablet contains: Eplerenone IP 50 mg Excipients q.s Colour: Red Oxide of Iron and Titanium Dioxide IP |
| 7. | Eplerenone Tablets IP 25 mg | Each film coated tablet contains: Eplerenone IP 25 mg Excipients q.s Colour: Yellow Oxide of Iron and Titanium Dioxide IP |
| 8. | Solifenacin Succinate Tablets IP 5 mg | Each film coated tablet contains: Solifenacin Succinate IP 5 mg Excipients q.s Colour : Ferric Oxide USP NF Yellow & Titanium Dioxide IP |
| 9. | Solifenacin Succinate Tablets IP 10 mg | Each film coated tablet contains: Solifenacin Succinate IP 10 mg Excipients q.s Colour : Ferric Oxide USP NF Red & Titanium Dioxide IP |
| 10. | Rivaroxaban Tablets 2.5 mg | Each film coated tablet contains: Rivaroxaban 2.5 mg Excipients q.s Colour : Ferric Oxide Yellow USP-NF & Titanium Dioxide IP |
| 11. | Rivaroxaban Tablets 10 mg | Each film coated tablet contains: Rivaroxaban 10 mg Excipients q.s Colour : Ferric Oxide Red USP-NF & Titanium Dioxide IP |
| 12. | Rivaroxaban Tablets 15 mg | Each film coated tablet contains: Rivaroxaban 15 mg Excipients q.s Colour : Ferric Oxide Red USP-NF & Titanium Dioxide IP |
| 13. | Nebivolol Tablets IP 5 mg | Each uncoated tablet contains: Nebivolol Hydrochloride IP Equivalent to Nebivolol 5 mg Excipients q.s |
| 14. | Nebivolol Hydrochloride & Telmisartan Tablets | Each uncoated bilayered tablet contains: Nebivolol Hydrochloride IP Equivalent to Nebivolol 5 mg Telmisartan IP 40 mg Excipients q.s |
| 15. | Nebivolol Hydrochloride & Telmisartan Tablets | Each uncoated bilayered tablet contains: Nebivolol Hydrochloride IP Equivalent to Nebivolol 2.5 mg Telmisartan IP 40 mg Excipients q.s |
| 16. | Perindopril Erbumine Tablets IP 4 mg | Each uncoated tablet contains: Perindopril Erbumine IP 4 mg Excipients q.s |
| 17. | Perindopril Erbumine Tablets IP 8 mg | Each uncoated tablet contains: Perindopril Erbumine IP 8 mg Excipients q.s |
| 18. | Metoprolol Succinate Extended Release Tablets IP 100 mg | Each film coated extended release tablet contains: Metoprolol Succinate IP 95 mg Equivalent to Metoprolol Tartrate 100 mg Excipients q.s Colour: Titanium Dioxide IP |
| 19. | Acebrophylline Sustained Release Tablets 200 mg | Each film coated tablet contains: Acebrophylline 200 mg (As Sustained Release) Excipients q.s Colour: Titanium Dioxide IP |
| 20. | Montelukast & Acebrophylline (Sustained Release) Tablets | Each Film Coated Tablet Contains: Acebrophylline 200 mg (As Sustained Release) Montelukast Sodium IP Equivalent to Montelukast 10 mg Excipients q.s. Colour: Quinoline Yellow |
| 21. | Pregabalin Tablets 50 mg | Each Film Coated Tablet Contains: Pregabalin IP 50 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 22. | Pregabalin Tablets 75 mg | Each Film Coated Tablet Contains: Pregabalin IP 75 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 23. | Rosuvastatin Tablets IP 40 mg | Each Film Coated Tablet Contains: Rosuvastatin Calcium IP Equivalent to Rosuvastatin 40 mg Excipients q.s Colour: Red Oxide of Iron and Titanium Dioxide IP |
| 24. | Ezetimibe Tablets IP 10 mg | Each uncoated tablet contains: Ezetimibe IP 10 mg Excipients q.s |
| 25. | Telmisartan & Bisoprolol Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg Telmisartan IP 40 mg Excipients q.s Colour : Ferric Oxide Red USP-NF & Titanium Dioxide IP |
| 26. | Metoprolol Succinate Extended Release Tablets IP 12.5 mg | Each Film Coated Extended Release Tablet Contains: Metoprolol Succinate IP 11.875 mg Equivalent to Metoprolol Tartrate 12.5 mg Excipients q.s Colour: Titanium Dioxide IP |
| 27. | Metoprolol Succinate Prolonged Release and Amlodipine Tablets IP | Each Film Coated Extended Release Tablet Contains: Metoprolol Succinate IP 23.75 mg Equivalent to Metoprolol Tartrate 25 mg Amlodipine Besylate IP Equivalent to Amlodipine 2.5 mg Excipients q.s Colour: Red Oxide of Iron |
| 28. | Telmisartan (Immediate Release) and Metoprolol (Extended Release)Tablets | Each uncoated Bilayered Tablet Contains: Telmisartan IP 40 mg (In Immediate Release Form) Metoprolol Succinate IP 47.5 mg Equivalent to Metoprolol Tartrate 50 mg (In Extended Release Form) Excipients q.s Colour: Sunset Yellow (In Metoprolol Layer) |
| 29. | Nebivolol Hydrochloride and Amlodipine Tablets IP | Each uncoated bilayered tablet contains: Nebivolol Hydrochloride IP Eq. to Nebivolol 5 mg Amlodipine Besylate IP Eq. to Amlodipine 2.5 mg Excipients q.s |
| 30. | Nebivolol Tablets IP 10 mg | Each uncoated tablet contains: Nebivolol Hydrochloride IP Equivalent to Nebivolol 10 mg Excipients q.s |
| 31. | Nebivolol and Hydrochlorothiazide Tablets | Each uncoated tablet contains: Nebivolol Hydrochloride IP Equivalent to Nebivolol 5 mg Hydrochlorothiazide IP 12.5 mg Excipients q.s |
| 32. | Cilnidipine and Nebivolol Tablets | Each uncoated tablet contains: Nebivolol Hydrochloride IP Equivalent to Nebivolol 5 mg Cilnidipine IP 10 mg Excipients q.s |
| 33. | Cilnidipine , Metoprolol Succinate ( Extended Release) And Telmisartan Tablets | Each film coated tablet contains: Cilnidipine IP 10 mg Metoprolol Succinate IP 47.5 mg Equivalent to Metoprolol Tartrate 50 mg Telmisartan IP 40 mg Excipients q.s Colour: Yellow Oxide of Iron and Titanium Dioxide IP |
| 34. | Telmisartan, Amlodipine and Chlorthalidone Tablets | Each Film coated Bilayered Tablet Contains: Telmisartan IP 40 mg Amlodipine Besylate IP Equivalent to Amlodipine 5 mg Chlorthalidone IP 12.5 mg Excipients q.s Colour: Red Oxide of Iron and Titanium Dioxide IP |
| 35. | Thyroxine sodium Tablets IP 12.5 mcg | Each uncoated tablet contains: Thyroxine sodium IP Equivalent to anhydrous Thyroxine Sodium 12.5 mcg (Synthetic Thyroid Hormone) Excipients q.s |
| 36. | Thyroxine sodium Tablets IP 25 mcg | Each uncoated tablet contains: Thyroxine sodium IP Equivalent to anhydrous Thyroxine Sodium 25 mcg (Synthetic Thyroid Hormone) Excipients q.s Colour : Sunset Yellow FCF |
| 37. | Thyroxine sodium Tablets IP 37.5 mcg | Each uncoated tablet contains: Thyroxine sodium IP Equivalent to anhydrous Thyroxine Sodium 37.5 mcg (Synthetic Thyroid Hormone) Excipients q.s Colour : Lake sunset Yellow and Ferric oxide yellow |
| 38. | Thyroxine sodium Tablets IP 50 mcg | Each uncoated tablet contains: Thyroxine sodium IP Equivalent to anhydrous Thyroxine Sodium 50 mcg (Synthetic Thyroid Hormone) Excipients q.s |
| 39. | Thyroxine sodium Tablets IP 62.5 mcg | Each uncoated tablet contains: Thyroxine sodium IP Equivalent to anhydrous Thyroxine Sodium (Synthetic Thyroid Hormone) Excipients Colour : Sunset Yellow FCF 62.5 mcg q.s |
| 40. | Thyroxine sodium Tablets IP 75 mcg | Each uncoated tablet contains: Thyroxine sodium IP Equivalent to anhydrous 75 mcg q.s Thyroxine Sodium (Synthetic Thyroid Hormone) Excipients Colour : Brilliant Blue FCF |
| 41. | Thyroxine sodium Tablets IP 100 mcg | Each uncoated tablet contains: Thyroxine sodium IP Equivalent to anhydrous Thyroxine Sodium (Synthetic Thyroid Hormone) Excipients 100 mcg q.s |
| 42. | Thyroxine sodium Tablets IP 112 mcg | Each uncoated tablet contains: Thyroxine sodium IP Equivalent to anhydrous Thyroxine Sodium (Synthetic Thyroid Hormone) Excipients Colour : Ponceau 4R 112 mcg q.s |
| 43. | Thyroxine sodium Tablets IP 88 mcg | Each uncoated tablet contains: Thyroxine sodium IP Equivalent to anhydrous Thyroxine Sodium (Synthetic Thyroid Hormone) Excipients Colour : Carmoisine 88 mcg q.s |
| 44. | Amlodipine and Indapamide (SR) Tablets | Each uncoated Bilayered Tablet Conta Amlodipine Besylate IP ins: 5 mg Equivalent to Amlodipine Indapamide IP 1.5 mg (As sustained Release Form ) Excipients |
| 45. | Indapamide Sustained-Release Tablets IP 1.5 mg | Each film coated tablet contains: Indapamide IP 1.5 mg (As sustained Release Form ) Excipients Colour: Titanium Dioxide IP |
| 46. | Amantadine Hydrochloride Tablets 100 mg | Each uncoated tablet contains: Amantadine Hydrochloride IP 100 mgExcipients |
| 47. | Tapentadol Extended Release Tablets 50 mg | Each film coated tablet contains: Tapentadol Hydrochloride IP Equivalent to Tapentadol 50 mg Excipients q.s Colour: Titanium Dioxide IP |
| 48. | Pitavastatin Tablets 2 mg | Each Film coated tablet Contains: Pitavastatin Calcium IP Equivalent To Pitavastatin Excipients Colour : Titanium Dioxide IP |
| 49. | Pitavastatin Tablets 1 mg | Each Film coated tablet Contains: Pitavastatin Calcium IP Equivalent To Pitavastatin Excipients Colour : Titanium Dioxide IP 1 mg q.s. |
| 50. | Pitavastatin and Fenofibrate Tablets | Each Film coated tablet Contains: Pitavastatin Calcium IP Equivalent To Pitavastatin 2 mg Fenofibrate IP 67.5 mg Excipients q.s. Colour : Titanium Dioxide IP |
| 51. | Rosuvastatin and Fenofibrate Tablets IP | Each Film Coated Tablet Contains: Rosuvastatin Calcium IP Equivalent to Rosuvastatin Fenofibrate IP Excipients q.s Colour : Titanium Dioxide I.P. 5 mg 160 mg |
| 52. | Cilnidipine and Nebivolol Tablets | Each uncoated tablet contains: Nebivolol Hydrochloride IP Equivalent to Nebivolol 2.5 mg Cilnidipine IP 10 mg Excipients q.s |
| 53. | Cilnidipine 10 mg and Metoprolol Succinate (SR) 50 mg Tablets | Each Film Coated Tablet Contains: Cilnidipine IP 10 mg Metoprolol Succinate IP 47.5 mg Equivalent to Metoprolol Tartrate 50 mg (In Extended Release Form) Excipients q.s Colour : Lake Sunset Yellow and Titanium Dioxide IP |
| 54. | Bisoprolol Fumarate and S-Amlodipine Besylate Tablets | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP S-Amlodipine Besylate IP Equivalent To S - Amlodipine Base Excipients Colours : Titanium Dioxide IP 5mg 2.5mg q.s. |
| 55. | Nebivolol Hydrochloride and S-Amlodipine Tablets IP | Each uncoated tablet contains: Nebivolol Hydrochloride IP Eq. to Nebivolol 5 mg S-Amlodipine Besylate IP Eq. to S- Amlodipine 2.5 mg Excipients q.s |
| 56. | Bisoprolol Fumarate Tablets 1.25 mg | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP 1.25 mg Excipients q.s Colour: Ponceau 4R Lake, Indigo carmine Aluminium lake & Titanium Dioxide IP |
| 57. | Bisoprolol Fumarate Tablets 2.5 mg | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP 2.5 mg Excipients q.s Colour: Titanium Dioxide IP |
| 58. | Bisoprolol Fumarate Tablets 5 mg | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP 5 mg Excipients q.s Colours: Yellow oxide of Iron and Titanium Dioxide IP |
| 59. | Telmisartan & Bisoprolol Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg Telmisartan IP 40 mg Excipients q.s Colours : Ferric Oxide Yellow USP-NF & Titanium Dioxide IP |
| 60. | Levetiracetam Tablets IP 1000 mg | Each Film Coated Tablet Contains : Levetiracetam IP 1000 mg Excipients q.s Colours: Red Oxide of Iron and Titanium Dioxide IP |
| 61. | Cinacalcet Tablets 30 mg | Each film coated tablets contains Cinacalcet Hydrochloride IP Equivalent to Cinacalcet 30 mg Excipients q.s Colours: Ferric Oxide Yellow USP-NF, Indigo carmine Aluminium lake & Titanium Dioxide IP |
| 62. | Paroxetine Hydrochloride Tablets IP 37.5 mg | Each Film Coated Prolonged-Release Tablet Contains : Paroxetine Hydrochloride IP Equivalent to Paroxetine 37.5 mg Excipients q.s. Colours: Ferric Oxide Red USP-NF and Titanium Dioxide IP |
| 63. | Montelukast, Ambroxol Hcl & Levocetirizine Dihydrochloride Tablets | Each film coated Tablets Contains Levocetirizine Dihydrochloride IP 5 mg Montelukast Sodium IP Equivalent to Montelukast 10 mg Ambroxol Hcl IP 30 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 64. | Torsemide and spironolactone Tablets | Each uncoated tablet contains: Torsemide IP 10 mg Spironolactone IP 50 mg Excipients q.s. |
| 65. | Torsemide and spironolactone Tablets | Each uncoated tablet contains: Torsemide IP 10 mg Spironolactone IP 25 mg Excipients q.s. |
| 66. | Memantine Hydrochloride Tablets IP 5 mg | Each film coated Tablets Contains Memantine Hydrochloride IP 5 mg Excipients q.s. Colours: Ferric Oxide Red USP-NF and Titanium Dioxide IP |
| 67. | Memantine Hydrochloride Tablets IP 10 mg | Each film coated Tablets Contains Memantine Hydrochloride IP 10 mg Excipients q.s. Colours: Ferric Oxide Red USP-NF and Titanium Dioxide IP |
| 68. | Pirfenidone Tablets IP 200 mg | Each film coated Tablets Contains Pirfenidone IP 200 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 69. | Pirfenidone Tablets IP 400 mg | Each film coated Tablets Contains Pirfenidone IP 400 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 70. | Acebrophylline(SR) and Montelukast Tablets | Each Film Coated Tablet Contains: Acebrophylline 200 mg (As Sustained Release) Monotelukast Sodium IP Equivalent to Montelukast 10 mg Excipients q.s. Colour: Sunset Yellow |
| 71. | Tenofovir Disoproxil Fumarate Tablets IP 300 mg | Each Film Coated Tablet Contains: Tenofovir Disoproxil Fumarate IP 300 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 72. | Cinnarizine and Dimenhydrinate Tablets | Each uncoated tablet contains: Cinnarizine IP 20 mg Dimenhydrinate BP 40 mg Excipients q.s |
| 73. | Citicoline Tablets IP 500 mg | Each Film Coated Tablet Contains: Citicoline Sodium IP Equivalent To Citicoline 500 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 74. | Citicoline and Piracetam Tablets | Each Film Coated Tablet Contains: Piracetam IP 800 mg Citicoline Sodium IP Equivalent To Citicoline 500 mg Excipients q.s. |
| Colour: Red oxide of Iron, Titanium Dioxide IP | ||
| 75. | Gliclazide Modified Release Tablets 30 mg | Each uncoated modified Release Tablets Contains: Gliclazide IP 30 mg Excipients q.s. |
| 76. | Gliclazide Modified Release Tablets 40 mg | Each uncoated Modified Release tablet contains: Gliclazide IP 40mg Excipients q.s. |
| 77. | Gliclazide Modified Release Tablets 60 mg | Each uncoated modified Release Tablets Contains: Gliclazide IP 60 mg Excipients q.s. |
| 78. | Gliclazide Modified Release Tablets 80 mg | Each uncoated modified Release Tablets Contains: Gliclazide IP 80 mg Excipients q.s. |
| 79. | Brivaracetam Tablets IP 100 mg | Each Film Coated Tablet Contains: Brivaracetam IP 100mg Excipients q.s. Colours : Red Oxide of Iron, Yellow Oxide of Iron and Titanium Dioxide IP |
| 80. | Rosuvastatin and Fenofibrate Tablets IP | Each Film Coated Tablet Contains: Rosuvastatin Calcium IP Equivalent to Rosuvastatin 10mg Fenofibrate IP 67mg Excipients q.s Colour : Sunset Yellow |
| 81. | Rosuvastatin and Fenofibrate Tablets IP | Each Film Coated Tablet Contains: Rosuvastatin Calcium IP Equivalent to Rosuvastatin 10mg Fenofibrate IP 160mg Excipients q.s Colour : Sunset Yellow |
| 82. | Rosuvastatin and Fenofibrate Tablets IP | Each Film Coated Tablet Contains: Rosuvastatin Calcium IP Equivalent to Rosuvastatin 10 mg Fenofibrate IP 80 mg Excipients q.s Colour : Sunset Yellow |
| 83. | Epalrestat Sustained release Tablets 150 mg | Each Film Coated Sustained release Tablet Contains: Epalrestat IP 150 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 84. | Dapagliflozin and Vildagliptin sustained-release Tablet 10mg/100mg | Each Bilayered Tablet Contains: Vildagliptin IP (Sustained-release) 100mg Dapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin 10mg |
| Excipients q.s Colour: Ferric Oxide Yellow USP-NF | ||
| 85. | Azilsartan Medoxomil and Chlorthalidone Tablets | Each Film coated bi-layered Tablet Contains : Azilsartan Kamedoxomil 40 mg Equivalent to Azilsartan medoxomil Chlorthalidone IP 12.5 mg Excipients q.s. Colour: Ferric Oxide Red , Ferric Oxide Yellow & Titanium Dioxide IP |
| 86. | Azelnidipine and Telmisartan Tablets | Each uncoated bi-layered Tablet Contains: Azelnidipine IP 8 mg Telmisartan IP 40 mg Excipients q.s Colour: Ponceau 4R ( in Telmisartan Layer ) |
| 87. | Voglibose Tablets IP 0.3 mg | Each uncoated tablet contains: Voglibose IP 0.3mg Excipients q.s |
| 88. | Doxofylline Sustained Release 650 mg Tablets | Each uncoated Sustained Release tablet Contains : Doxofylline IP 650mg Excipients q.s |
| 89. | Teneligliptin Tablets IP 20mg | Each Film Tablet Contains: Teneligliptin Hydrobromide Hydrate IP Equivalent to Teneligliptin 20 mg Excipients q.s. Colour: Ferric oxide Yellow USP-NF & & Titanium Dioxide IP |
| 90. | Gliclazide 80mg and Metformin Hydrochloride 500mg Tablets | Each Film Coated tablet contains: Gliclazide I.P. 80 mg Metformin Hydrochloride I.P. 500 mg Excipients q.s. Colour: Titanium dioxide I.P. |
| 91. | Gliclazide 40 mg & Metformin Hydrochloride 500 mg Tablets | Each Film Coated tablet contains: Gliclazide I.P. 40mg Metformin Hydrochloride I.P. 500mg Excipients q.s. Colour: Titanium dioxide I.P. |
| 92. | Gliclazide 60 mg (Modified Release) & Metformin Hydrochloride 500 mg (Sustained Release) Tablets | Each uncoated bilayered tablet contains: Gliclazide IP 60mg (Modified Release) Metformin Hydrochloride IP 500mg (Sustained Release) Colour: Sunset Yellow (Gliclazide Layer) |
| 93. | Metformin Hydrochloride Sustained Release Tablets IP 500 mg | Each uncoated sustained release tablet contains: Metformin Hydrochloride IP 500mg (As Sustained Release form) Excipients q.s. |
| 94. | Metformin Hydrochloride Sustained Release Tablets IP 850 mg | Each uncoated sustained release tablet contains: Metformin Hydrochloride IP 850 mg (As Sustained Release form) Excipients q.s. |
| 95. | Metformin Hydrochloride Sustained Release Tablets IP 1000 mg | Each uncoated sustained release tablet contains: Metformin Hydrochloride IP 1000mg (As Sustained Release form) Excipients q.s. |
| 96. | Glimepiride Tablets IP 4 mg | Each Uncoated Tablet Contains: Glimepiride IP Excipients |
| 97. | Glimepiride Tablets IP 3 mg | Each Uncoated Tablet Contains: Glimepiride IP Excipients |
| 98. | Glimepiride Tablets IP 2 mg | Each Uncoated Tablet Contains: Glimepiride IP Excipients |
| 99. | Glimepiride Tablets IP 1 mg | Each Uncoated Tablet Contains: Glimepiride IP Excipients |
| 100. | Cinnarizine & Dimenydrinate tablets | Each Uncoated Tablet Contains: Cinnarizine IP 20 mg Dimenydrinate BP 40 mg Excipients q.s |
| 101. | Cilostazol Tablet IP 50 mg | Each Uncoated Tablet Contains: Cilostazol IP 50 mg Excipients q.s |
| 102. | Cilostazol Tablet IP 100 mg | Each Uncoated Tablet Contains: Cilostazol IP 100 mg Excipients q.s |
| 103. | Thyroxine Sodium Tablets IP 125 mcg | Each Uncoated Tablet Contains: Thyroxine Sodium IP 125 mcg (As anhydrous) Excipients q.s |
| 104. | Thyroxine Sodium Tablets IP 150 mcg | Each Uncoated Tablet Contains: Thyroxine Sodium IP 150 mcg (As anhydrous) Excipients q.s |
| 105. | Valsartan Tablets I.P. 40 mg | Each Film Coated tablet contains: Valsartan IP 40mg Excipients q.s Colour: Yellow Oxide of Iron |
| 106. | Valsartan Tablets I.P. 80 mg | Each Film Coated tablet contains: Valsartan IP 80mg Excipients q.s Colour: Yellow Oxide of Iron |
| 107. | Valsartan Tablets I.P. 160 mg | Each Film Coated tablet contains: Valsartan IP 160mg |
| Excipients q.s Colour: Titanium dioxide IP | ||
| 108. | Valsartan Tablets I.P. 320 mg | Each Film Coated tablet contains: Valsartan IP 320mg Excipients q.s Colour: Yellow Oxide of Iron |
| 109. | Voglibose & Metformin HCl (SR) Tablets | Each uncoated bilayered tablet contains: Voglibose IP 0.2 mg Metformin Hydrochloride IP 500 mg (As Sustained Release) Excipients q.s Colour: Sunset yellow (In Voglibose layer) |
| 110. | Voglibose & Metformin HCl. (SR) Tablets | Each uncoated bilayered tablet contains: Voglibose IP 0.3 mg Metformin Hydrochloride IP 500 mg (As Sustained Release) Excipients q.s Colour: Poceau 4R (In Voglibose layer) |
| 111. | Glimepiride & Metformin Hydrochloride (SR) Tablets IP | Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg (As Sustained Release) Colour: Ponceau 4R (in Glimepiride layer) |
| 112. | Metformin Hydrochloride Sustained release and Glimepiride Tablets I.P | Each uncoated bilayered tablet contains: Glimepiride IP 0.5 mg Metformin Hydrochloride IP 500 mg (As Sustained Release) Colour: Ponceau 4R (in Glimepiride layer) |
| 113. | Metformin Hydrochloride Sustained release and Glimepiride Tablets I.P | Each uncoated bilayered tablet contains: Glimepiride IP 0.5 mg Metformin Hydrochloride IP 1000 mg (As Sustained Release) Colour: Lake of Indigo (in Glimepiride layer) |
| 114. | Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP | Each modified release bilayered tablet contains: Glimepiride IP 3 mg Metformin Hydrochloride IP 500 mg (As Prolonged Release form ) Colour: Tartrazine Lake (in Glimepiride layer) |
| 115. | Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP | Each modified release bilayered tablet contains: Glimepiride IP 4 mg Metformin Hydrochloride IP 500 mg (As Prolonged Release form ) Colour: Red of Iron (in Glimepiride layer) |
| 116. | Voglibose Tablets IP 0.2 mg | Each uncoated Tablet Contains : Voglibose I.P. 0.2 mg Excipients q.s |
| 117. | Nateglinide and Metformin Hydrochloride Tablets | Each Film coated tablet contains : Nateglinide U.S.P. 60 mg Metformin Hydrochloride I.P. 500 mg |
| Excipients q.s. Colour: Sunset Yellow | ||
| 118. | Diltiazem Hydrochloride sustained release Tablets 60 mg | Each film coated sustained release tablet contains: Diltiazem Hydrochloride IP 60 mg Excipients q.s. Colour: Sunset Yellow |
| 119. | Diltiazem Hydrochloride sustained release Tablets 30 mg | Each film coated sustained release tablet contains: Diltiazem Hydrochloride IP 30 mg Excipients q.s. Colour: Sunset Yellow |
| 120. | Flupirtine Maleate & Paracetamol Tablets | Each uncoated bilayered tablet contains: Flupirtine Maleate 100 mg Paracetamol IP 325 mg Excipients q.s. Colour: Iron oxide Red (In Flupirtine layer) |
| 121. | Prochloperazine Maleate Mouth Dissolving Tablets | Each uncoated Mouth Dissolving tablet contains: Prochloperazine Maleate IP 5 mg Excipients q.s. |
| 122. | Norethisterone controlled release tablets 10mg | Each uncoated controlled release tablet contains: Norethisterone IP 10 mg Excipients q.s. |
| 123. | Norethisterone controlled release tablets 15 mg | Each uncoated controlled release tablet contains: Norethisterone IP 15 mg Excipients q.s. |
| 124. | Thiocolchicoside and Aceclofenac Tablets | Each film coated tablet contains: Thiocolchicoside IP 4 mg Aceclofenac IP 100 mg Excipients q.s. Colour: Quinoline Yellow WS |
| 125. | Thiocolchicoside and Aceclofenac Tablets | Each film coated tablet contains: Thiocolchicoside IP 8 mg Aceclofenac IP 100 mg Excipients q.s. Colour: Quinoline Yellow WS |
| 126. | Gabapentin and Amitriptyline Hydrochloride Tablets | Each film coated Tablets contains : Gabapentin IP 300 mg Amitriptyline Hydrochloride IP 10 mg Excipients q.s Colour : Red oxide of Iron |
| 127. | Gabapentin and Amitriptyline Hydrochloride Tablets | Each film coated Tablets contains : Gabapentin IP 100 mg Amitriptyline Hydrochloride IP 10 mg Excipients q.s Colour : Red oxide of Iron |
| 128. | Gabapentin 200 mg and Nortriptyline 5 mg Tablets | Each Film Coated Tablet Contains: Gabapentin IP 200 mg Nortriptyline Hydrochloride IP Equivalent to Nortriptyline 5 mg Excipients q.s |
| Colour: Sunset Yellow | ||
| 129. | Lornoxicam and Thiocolchicoside Tablets | Each film coated tablet contains: Lornoxicam 4 mg Thiocolchicoside IP 4 mg Excipients q.s Colour: Quinoline Yellow WS |
| 130. | Lornoxicam and Thiocolchicoside Tablets | Each film coated tablet contains: Lornoxicam 4 mg Thiocolchicoside IP 8 mg Colour: Quinoline Yellow WS |
| 131. | Lornoxicam and Thiocolchicoside Tablets | Each film coated tablet contains: Lornoxicam 8 mg Thiocolchicoside IP 4 mg Excipients q.s Colour: Quinoline Yellow WS |
| 132. | Sultamicillin Tablets 375 mg | Each film coated tablet contains: Sultamicillin (As Tosylate) BP 375 mg (Eq. to Sulbactam 147 mg and Ampicillin 220 mg) Excipients q.s Colour: Titanium dioxide IP |
| 133. | Aceclofenac, Paracetamol and Thiocolchicoside Tablets | Each film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg Thiocolchicoside IP 8 mg Excipients q.s Colour: Brilliant Blue |
| 134. | Sitagliptin and Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg (As Extended-Release) Excipients q.s. Colours: Titanium Dioxide IP, Indigo Carmine Aluminium Lake |
| 135. | Aceclofenac, Paracetamol and Thiocolchicoside Tablets | Each film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg Thiocolchicoside IP 4 mg Excipients q.s Colour: Brilliant Blue |
| 136. | Levocetirizine Dihydrochloride, Montelukast and Ambroxol HCl. (SR) Tablets | Each film coated Tablets Contains: Levocetirizine Dihydrochloride IP 5 mg Montelukast Sodium IP Equivalent to Montelukast 10 mg Ambroxol HCl. IP 75 mg (As Sustained release) Excipients q.s. Colour: Quinoline Yellow Lake |
| 137. | Bempedoic Acid Tablets | Each film coated Tablets Contains: Bempedoic Acid 180 mg Excipients q.s Colour: Titanium Dioxide IP |
| 138. | Prasugrel Tablets IP 5 mg | Each film coated Tablets Contains: Prasugrel Hydrochloride IP Eq. to Prasugrel 5 mg Colours: Ferric Oxide (Yellow) USP-NF & Titanium dioxide IP |
| 139. | Prasugrel Tablets IP 10 mg | Each film coated Tablets Contains: Prasugrel Hydrochloride IP Eq. to Prasugrel 10 mg Colours: Ferric Oxide (Yellow) USP-NF & Titanium dioxide IP |
| 140. | Aspirin & Prasugrel Hydrochloride Tablets | Each enteric coated tablet contains: Aspirin IP 75 mg Prasugrel Hydrochloride IP Eq. to Prasugrel 10 mg Colours: Ferric Oxide (Red) USP-NF & Titanium dioxide IP |
| 141. | Tetrabenazine Tablets 25 mg | Each uncoated Tablets Contains: Tetrabenazine 25 mg Excipients q.s Colour: Ferric Oxide (Yellow) USP-NF |
| 142. | Tetrabenazine Tablets 12.5 mg | Each uncoated Tablets Contains: Tetrabenazine 12.5 mg Excipients q.s Colour: Ferric Oxide (Yellow) USP-NF |
| 143. | Tolperisone Hydrochloride Sustained Release Tablets 300 mg | Each film coated Sustained Release tablet contains: Tolperisone Hydrochloride 300 mg Excipients q.s. Colour : Ferric Oxide (Yellow) USP-NF |
| 144. | Tolperisone Hydrochloride Sustained Release Tablets 450 mg | Each film coated Sustained Release tablet contains: Tolperisone Hydrochloride 450 mg Excipients q.s. Colour : Ferric Oxide (Yellow) USP-NF |
| 145. | Tolperisone Hydrochloride and Paracetamol Tablets | Each film coated tablet contains: Tolperisone Hydrochloride 150 mg Paracetamol IP 325 mg Excipients q.s. Colour : Titanium dioxide IP |
| 146. | Tolperisone Hydrochloride and Diclofenac Sodium Tablets | Each film coated tablet contains: Tolperisone Hydrochloride 150 mg Paracetamol IP 50 mg Excipients q.s. Colour : Titanium dioxide IP |
| 147. | Etodolac and Tolperisone Hydrochloride Tablets | Each film coated tablet contains: Tolperisone Hydrochloride 150 mg Etodolac IP 400 mg Excipients q.s. Colour : Sunset Yellow FCF |
| 148. | Tolperisone Hydrochloride 450 mg & Diclofenac Sodium 100 mg (ER) Tablets | Each film coated bilayered extended release tablet contains: Tolperisone Hydrochloride 450 mg Diclofenac Sodium IP 100 mg Excipients q.s. Colour : Sunset Yellow FCF |
| 149. | Carbamazepine Tablets IP 200 mg | Each uncoated tablet contains: Carbamazepine IP 200 mg Excipients q.s. |
| 150. | Carbamazepine Prolonged-release Tablets IP 100 mg | Each uncoated prolonged-release tablet contains: Carbamazepine IP 100 mg Excipients q.s. |
| 151. | Carbamazepine Prolonged-release Tablets IP 200 mg | Each uncoated prolonged-release tablet contains: Carbamazepine IP 200 mg Excipients q.s. |
| 152. | Carbamazepine Prolonged-release Tablets IP 400 mg | Each uncoated prolonged-release tablet contains: Carbamazepine IP 400 mg Excipients q.s. |
| 153. | Cabergoline Tablets I.P. 0.25 mg | Each uncoated tablet contains: Cabergoline IP 0.25 mg Excipients q.s. |
| 154. | Cabergoline Tablets I.P. 0.5 mg | Each uncoated tablet contains: Cabergoline IP 0.5 mg Excipients q.s. |
| 155. | Cabergoline Tablets I.P. 1 mg | Each uncoated tablet contains: Cabergoline IP 1 mg Excipients q.s. |
| 156. | Lithium Carbonate Tablets I.P. 300 mg | Each uncoated tablet contains: Lithium Carbonate IP 300 mg Excipients q.s. |
| 157. | Lithium Carbonate Prolonged-release Tablets I.P. 300 mg | Each uncoated prolonged-release tablet contains: Lithium Carbonate IP 300 mg Excipients q.s. |
| 158. | Lithium Carbonate Prolonged-release Tablets I.P. 400 mg | Each uncoated prolonged-release tablet contains: Lithium Carbonate IP 400 mg Excipients q.s. |
| 159. | Lithium Carbonate Prolonged-release Tablets I.P. 450 mg | Each uncoated prolonged-release tablet contains: Lithium Carbonate IP 450 mg Excipients q.s. |
| 160. | Risperidone Orally disintegrating Tablets USP 0.5 mg | Each uncoated Orally disintegrating tablet contains Risperidone IP 0.5 mg Excipients q.s. |
| 161. | Risperidone Orally disintegrating Tablets USP 1 mg | Each uncoated Orally disintegrating tablet contains Risperidone IP 1 mg Excipients q.s. |
| 162. | Risperidone Tablets IP 1 mg | Each uncoated tablet contains Risperidone IP 1 mg Excipients q.s. |
| 163. | Risperidone Tablets IP 2 mg | Each uncoated tablet contains Risperidone IP 2 mg Excipients q.s. |
| 164. | Risperidone Tablets IP 3 mg | Each uncoated tablet contains Risperidone IP 3 mg Excipients q.s. |
| 165. | Risperidone Tablets IP 4 mg | Each uncoated tablet contains Risperidone IP 4 mg Excipients q.s. |
| 166. | Risperidone & Trihexyphenidyl Hydrochloride Tablets | Each film coated tablet contains Risperidone IP 2 mg Trihexyphenidyl Hydrochloride IP 2 mg Excipients q.s. Colours : Red Oxide of Iron & Titanium dioxide IP |
| 167. | Risperidone & Trihexyphenidyl Hydrochloride Tablets | Each film coated tablet contains Risperidone IP 3 mg Trihexyphenidyl Hydrochloride IP 2 mg Excipients q.s. Colours : Red Oxide of Iron & Titanium dioxide IP |
| 168. | Risperidone & Trihexyphenidyl Hydrochloride Tablets | Each film coated tablet contains Risperidone IP 4 mg Trihexyphenidyl Hydrochloride IP 2 mg Excipients q.s. Colours : Red Oxide of Iron & Titanium dioxide IP |
| 169. | Pregabalin Extended Release Tablets 82.5 mg | Each film coated Extended Release tablet contains: Pregabalin IP 82.5 mg Excipients q.s. Colours : Indigo Carmine & Titanium dioxide IP |
| 170. | Paracetamol Sustained Release Tablets 1000 mg | Each uncoated bilayered Tablet contains: Paracetamol IP 300 mg (As Immediate release) Paracetamol IP 700 mg (As sustained release) Excipients q.s. Colours : Carmoisine |
| 171. | Primidone Tablets USP 25 mg | Each film coated tablet contains: Primidone USP 25 mg Excipients q.s. Colours : Yellow Oxide of Iron |
| 172. | Primidone Tablets USP 50 mg | Each film coated tablet contains: Primidone USP 50 mg Excipients q.s. Colours : Yellow Oxide of Iron |
| 173. | Pirfenidone Tablets IP 600 mg | Each film coated Tablets Contains Pirfenidone IP 600 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 174. | Pirfenidone Tablets IP 801 mg | Each film coated Tablets Contains Pirfenidone IP 801 mg |
| Excipients q.s. Colour: Titanium Dioxide IP | ||
| 175. | Oxaceprol Tablets 200mg | Each film coated tablet contains: Oxaceprol 200 mg Excipients q.s. Colour: Tartrazine |
| 176. | Simethicone & Activated Charcoal Tablet | Each dual coated tablet contains: Outer Layer (sugar coated for gastric release) Simethicone IP 80 mg Inner Layer (Enteric coated for intestinal release) Activated Charcoal IP 250 mg Excipients q.s. Colour: Sunset Yellow FCF, Ponceau 4R , Ferric Oxide Red USP NF (Red Oxide of Iron) & Titanium dioxide IP |
| 177. | Cyclophosphamide Tablet IP 50 mg | Each sugar coated tablet contains: Cyclophosphamide IP 53.5 mg Eq. to Cyclophosphamide anhydrous 50 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 178. | Ramipril and Metoprolol Succinate extended release Tablets | Each uncoated bilayered tablet contains: Ramipril IP 2.5 mg Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (as extended release) Excipients q.s. Colour: Red Ferric Oxide |
| 179. | Ramipril and Metoprolol Succinate extended release Tablets | Each uncoated bilayered tablet contains: Ramipril IP 5 mg Metoprolol Succinate IP 47.5 mg Eq. to Metoprolol Tartrate 50 mg (as extended release) Excipients q.s. Colour: Red Ferric Oxide |
| 180. | Azelnidipine Tablets IP 8 mg | Each uncoated Tablet Contains: Azelnidipine IP 8 mg Excipients q.s |
| 181. | Azelnidipine Tablets IP 16 mg | Each uncoated Tablet Contains: Azelnidipine IP 16 mg Excipients q.s |
| 182. | Repaglinide Tablets I.P. 0.5 mg | Each uncoated tablet contains : Repaglinide IP 0.5 mg Excipients q.s |
| 183. | Repaglinide Tablets I.P. 1 mg | Each uncoated tablet contains : Repaglinide IP 1 mg Excipients q.s |
| 184. | Repaglinide Tablets I.P. 2 mg | Each uncoated tablet contains : Repaglinide IP 2 mg Excipients q.s |
| 185. | Repaglinide and Metformin Hydrochloride Tablets I.P. | Each film coated tablet contains: Repaglinide IP 1 mg Metformin Hydrochloride IP 500 mg Excipients q.s Colour: Yellow oxide of Iron |
| 186. | Repaglinide and Metformin Hydrochloride Tablets I.P. | Each film coated tablet contains: Repaglinide IP 2 mg Metformin Hydrochloride IP 500 mg Excipients q.s Colour: Yellow oxide of Iron |
| 187. | Repaglinide and Metformin Hydrochloride SR Tablets | Each uncoated bilayered tablet contains: Repaglinide IP 1 mg Metformin Hydrochloride IP 500 mg (as sustained release form) Excipients q.s Colour: Yellow oxide of Iron |
| 188. | Repaglinide and Metformin Hydrochloride SR Tablets | Each uncoated bilayered tablet contains: Repaglinide IP 2 mg Metformin Hydrochloride IP 500 mg (as sustained release form) Excipients q.s Colour: Yellow oxide of Iron |
| 189. | Nebivolol Hydrochloride and Amlodipine Tablets IP | Each uncoated tablet contains: Nebivolol Hydrochloride IP Eq. to Nebivolol 5 mg Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s |
| 190. | Potassium Magnesium Citrate Tablets | Each Uncoated tablet contains: Potassium Magnesium Citrate 978 mg (Each tablet contains approx. 7 m Eq Potassium ion, 3.5 m Eq Magnesium ion, 10.5 m Eq Citrate Ion) Excipients q.s Colour: Sunset Yellow |
| 191. | Ropinirole Tablets IP 0.25 mg | Each film coated tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 0.25 mg Excipients q.s Colour: Titanium dioxide IP |
| 192. | Ropinirole Tablets IP 0.5 mg | Each film coated tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 0.5 mg Excipients q.s Colour: Quinoline Yellow WS & Brilliant Blue FCF |
| 193. | Ropinirole Tablets IP 1 mg | Each film coated tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 1 mg Excipients q.s Colour: Quinoline Yellow WS & Brilliant Blue FCF |
| 194. | Ropinirole Tablets IP 2 mg | Each film coated tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 2 mg Excipients q.s Colour: Quinoline Yellow WS & Brilliant Blue FCF |
| 195. | Ropinirole Tablets IP 5 mg | Each film coated tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 5 mg Excipients q.s Colour: Quinoline Yellow WS & Brilliant Blue FCF |
| 196. | Pregabalin and Nortriptyline Tablets | Each Film coated tablet contains : Pregabalin IP 50 mg Nortriptyline Hydrochloride IP Equivalent to Nortriptyline 10 mg Excipients q.s Colour: Titanium Dioxide IP |
| 197. | Carbimazole Tablets IP 5 mg | Each Uncoated tablet contains: Carbimazole IP 5 mg Excipients q.s |
| 198. | Carbimazole Tablets IP 10 mg | Each Uncoated tablet contains: Carbimazole IP 10 mg Excipients q.s |
| 199. | Carbimazole Tablets IP 20 mg | Each Uncoated tablet contains: Carbimazole IP 20 mg Excipients q.s |
| 200. | Phenytoin sodium Tablets 50 mg | Each Film coated tablet contains : Phenytoin sodium IP 50 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 201. | Phenytoin sodium Tablets 100 mg | Each Film coated tablet contains : Phenytoin sodium IP 100 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 202. | Modafinil Tablets IP 100 mg | Each Uncoated Tablet Contains : Modafinil IP 100 mg Excipients q.s |
| 203. | Modafinil Tablets IP 200 mg | Each Uncoated Tablet Contains : Modafinil IP 200 mg Excipients q.s |
| 204. | Opipramol Dihydrochloride Tablets 100 mg | Each Film coated tablet contains : Opipramol Dihydrochloride 100 mg Excipients q.s. Colour: Quinoline Yellow WS & Titanium Dioxide IP |
| 205. | Dapoxetine Tablets IP 30 mg | Each film coated tablet contains : Dapoxetine Hydrochloride IP Eq. to Dapoxetine 30 mg Excipients q.s. Colour: Brilliant Blue FCF |
| 206. | Dapoxetine Tablets IP 60 mg | Each film coated tablet contains : |
| Dapoxetine Hydrochloride IP Eq. to Dapoxetine 60 mg Excipients q.s. Colour: Brilliant Blue FCF | ||
| 207. | Pantoprazole Dual-release Gastro-resistant Tablets | Each Dual-release Gastro-resistant tablet contains : Pantoprazole Sodium IP Eq. to Pantoprazole 80 mg Excipients q.s. Colour: Ferric Oxide Yellow USP-NF, Ferric Oxide Red USP-NF & Titanium Dioxide IP |
| 208. | Carbidopa, Levodopa & Entacapone Tablets | Each film coated tablet contains : Carbidopa IP Eq. to anhydrous Carbidopa 37.5 mg Levodopa IP 150 mg Entacapone IP 200 mg Excipients q.s. Colour: Ferric Oxide Yellow USP-NF, Ferric Oxide Red USP-NF & Titanium Dioxide IP |
| 209. | Lamotrigine Dispersible Tablet IP 25 mg | Each Uncoated Dispersible Tablet Contains : Lamotrigine IP 25 mg Excipients q.s |
| 210. | Lamotrigine Dispersible Tablet IP 50 mg | Each Uncoated Dispersible Tablet Contains : Lamotrigine IP 50 mg Excipients q.s |
| 211. | Lamotrigine Dispersible Tablet IP 100 mg | Each Uncoated Dispersible Tablet Contains : Lamotrigine IP 100 mg Excipients q.s |
| 212. | Lamotrigine Tablet 50 mg | Each Uncoated Tablet Contains : Lamotrigine IP 50 mg Excipients q.s Colour: Ferric Oxide Yellow USP-NF |
| 213. | Paroxetine Extended Release and Clonazepam Tablets | Each Film Coated Tablet Contains : Paroxetine Hydrochloride IP Equivalent to Paroxetine 25 mg Clonazepam IP 0.5 mg Excipients q.s. Colours: Ferric Oxide Yellow USP-NF and Titanium Dioxide IP |
| 214. | Minoxidil Tablets I.P. 1.25 mg | Each Uncoated tablet Contains : Minoxidil IP 1.25 mg Excipients q.s |
| 215. | Minoxidil Tablets I.P. 2.5 mg | Each Uncoated tablet Contains : Minoxidil IP 2.5 mg Excipients q.s |
| 216. | Minoxidil Tablets I.P. 5 mg | Each Uncoated tablet Contains : Minoxidil IP 5 mg Excipients q.s |
| 217. | Minoxidil Tablets I.P. 10 mg | Each Uncoated tablet Contains : Minoxidil IP 10 mg Excipients q.s |
| 218. | Telmisartan, Amlodipine and Hydrochlorothiazide Tablets | Each uncoated tablet Contains: Telmisartan IP 40 mg Amlodipine Besylate IP Equivalent to Amlodipine 5 mg Hydrochlorothiazide IP 12.5 mg Excipients q.s |
| 219. | Diltiazem Hydrochloride sustained release Tablets 90 mg | Each uncoated sustained release tablet contains: Diltiazem Hydrochloride IP 90 mg Excipients q.s. |
| 220. | Sacubitril/ValsartanTablets200mg | Each Film Coated Tablet Contains: Sacubitril and Valsartan 200mg (97 mg+103mg) Excipients q.s Colours: Titanium Dioxide IP, Iron Oxide Red and Iron Oxide Black |
| 221. | Ketoconazole Tablets IP 200 mg | Each uncoated Tablet Contains : Ketoconazole IP 200 mg Excipients q.s |
| 222. | Propranolol hydrochloride tablets IP 10 mg | Each uncoated Tablet Contains : Propranolol hydrochloride IP 10 mg Excipients q.s |
| 223. | Propranolol hydrochloride tablets IP 20 mg | Each uncoated Tablet Contains : Propranolol hydrochloride IP 20 mg Excipients q.s |
| 224. | Propranolol hydrochloride tablets IP 40 mg | Each uncoated Tablet Contains : Propranolol hydrochloride IP 40 mg Excipients q.s |
| 225. | Propranolol hydrochloride Sustained-release tablets 40 mg | Each uncoated Sustained-release Tablet Contains: Propranolol hydrochloride IP 40 mg Excipients q.s |
| 226. | Propranolol hydrochloride Sustained-release tablets 80 mg | Each uncoated Sustained-release Tablet Contains: Propranolol hydrochloride IP 80 mg Excipients q.s |
| 227. | Gliclazide Extended-release Tablets 60 mg | Each uncoated Extended-release Tablets Contains: Gliclazide IP 60 mg Excipients q.s. |
| 228. | Tolvaptan Tablets 15 mg | Each uncoated tablet contains: Tolvaptan IP 15 mg Excipients q.s. Colour: Brilliant blue FCF |
| 229. | Tolvaptan Tablets 30 mg | Each uncoated tablet contains: Tolvaptan IP 30 mg Excipients q.s. Colour: Brilliant blue FCF |
| 230. | Sitagliptin and Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 50mg Metformin Hydrochloride IP 500 mg Excipients q.s. |
| Colours: Iron Oxide Yellow, Iron Oxide Red and Titanium Dioxide IP | ||
| 231. | Pioglitazone 15 mg & Metformin Hydrochloride (ER) 500 mg Tablets | Each uncoated bilayered tablet contains: Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg (as extended Release) Colour: Brilliant Blue FCF (in Pioglitazone layer) |
| 232. | Azelnidipine Tablets IP 8 mg | Each uncoated tablet contains: Azelnidipine IP 8 mg Excipients q.s. |
| 233. | Azelnidipine Tablets IP 16 mg | Each uncoated tablet contains: Azelnidipine IP 16 mg Excipients q.s. |
| 234. | Doxofylline & Ambroxol Hydrochloride Tablets | Each Film Coated Tablet Contains: Doxofylline IP 400mg Ambroxol Hydrochloride IP 30 mg Excipients q.s Colours: Titanium Dioxide IP |
| 235. | Doxofylline and Acebrophylline Tablets | Each uncoated tablet contains: Doxofylline IP 400 mg Acebrophylline 100 mg Excipients q.s. |
| 236. | Levocetirizine & Ambroxol Hydrochloride Tablets | Each uncoated tablet contains: Levocetirizine Dihydrochloride IP 5 mg Ambroxol Hydrochloride IP 60 mg Excipients q.s. |
| 237. | Levocetirizine & Ambroxol Hydrochloride Tablets | Each uncoated tablet contains: Levocetirizine Dihydrochloride IP 10 mg Ambroxol Hydrochloride IP 60 mg Excipients q.s. |
| 238. | Apremilast Tablets 30 mg | Each Film Coated Tablet Contains : Apremilast 30 mg Excipients q.s. Colours: Ferric Oxide Red USP-NF, Ferric Oxide Yellow, Ferrosoferric Oxide USP-NF & Titanium Dioxide IP |
| 239. | Hydroxychloroquine Sulphate Tablets IP 300 mg | Each film coated tablet contains: Hydroxychloroquine Sulphate IP 300 mg Ex{:ipients Colours: Titanium Dioxide IP |
| 240. | Hydroxychloroquine Sulphate Tablets IP 200 mg | Each film coated tablet contains: Hydroxychloroquine Sulphate IP 200 mg Excipients q.s. Colours: Titanium Dioxide IP |
| 241. | Hydroxychloroquine Sulphate Tablets IP 400 mg | Each film coated tablet contains: Hydroxychloroquine Sulphate IP 400 mg Excipients q.s.Colours: Titanium Dioxide IP |
| 242. | Hydroxyzine Hydrochloride Tablets IP 10 mg | Each Film Coated Tablet Contains : Hydroxyzine Hydrochloride IP 10 mg Excipients q.s. |
| Colour : Titanium Dioxide IP | ||
| 243. | Bisoprolol Fumarate and Amlodipine Besylate Tablets | Each Film Coated Tablet Contains: Bisoprolol Fumarate IP 5mg Amlodipine Besylate IP Equivalent to Amlodipine Base 2 5mg Excipients q.s. Colours : Ferric Oxide Red USP-NF & Titanium Dioxide IP |
| 244. | Nebivolol Hydrochloride and Amlodipine Tablets IP | Each uncoated tablet contains: NebivololHydrochloride IP Eq. to Nebivolol 5 mg Amlodipine Besylate IP Eq. to Amlodipine 2.5 mg Excipients q.s. |
| 245. | Nebivolol Hydrochloride and Amlodipine Tablets IP | Each uncoated tablet contains: NebivololHydrochloride IP Eq. to Nebivolol 5 mg Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients |
| 246. | Bisoprolol Fumarate and Hydrochlorothiazide Tablets | Each uncoated tablet contains: Bisoprolol Fumarate IP 2.5 mg Hydrochlorothiazide IP 6.25 mg Excipients q.s |
| 247. | Bisoprolol Fumarate and Hydrochlorothiazide Tablets | Each uncoated tablet contains: Bisoprolol Fumarate IP 5 mg Hydrochlorothiazide IP 6.25 mg Excipients q.s |
| 248. | Bisoprolol Fumarate and Hydrochlorothiazide Tablets | Each uncoated tablet contains: Bisoprolol Fumarate IP 10 mg Hydrochlorothiazide IP 6.25 mg Excipients q.s |
| 249. | Sodium Alendronate and Cholecalciferol Tablets | Each film coated Tablets Contains Sodium Alendronate IP Equivalent to Alendronic acid 70 mg Cholecalciferol IP 2000 IU Excipients q.s Colours : Sunset Yellow |
| 250. | Gabapentin and Methylcobalamin Tablets | Each film coated Tablets contains : Gabapentin IP 100 mg Methylcobalamin IP 500 mcg Excipients q.s Colours : Ponceau 4R , Titanium Dioxide IP |
| 251. | Pregabalin, Nortriptyline and Methylcobalamin Tablets | Each Film coated tablet contains : Pregabalin IP 75 mg Nortriptyline Hydrochloride IP Equivalent To Nortriptyline 10 mg Methylcobalamin IP 1500 mcg Excipients q.s Colour: Titanium Dioxide IP |
| 252. | Benfotiamine Tablets | Each Film coated tablet contains : Benfotiamine 100 mg Excipients q.s Colour: Titanium Dioxide IP |
| 253. | Amitriptyline Hydrochloride & Methylcobalamin Tablets | Each Film coated tablet contains : Amitriptyline Hydrochloride IP 5 mg Methylcobalamin IP 1500 mcg Excipients q.s Colour : Ponceau 4R |
| 254. | Alfa Ketoanalogue Tablets | Each Film coated tablet contains: Calcioum-3-Methyl-2-oxo-Valerate 67 mg (a Ketoanalogue to isoleucine, Calcium Salt) Calcioum-4-Methyl-2-oxo-Valerate 101 mg (a Ketoanalogue to leucine, Calcium Salt) Calcioum-2-oxo-3 Phenyl propionate 68 mg (a Ketoanalogue to Phenylalanine, Calcium Salt) Calcioum-3-methyl-2-oxo-butyate 86 mg (a Ketoanalogue to valine, Calcium Salt) Calcioum-DL-2-hydroxy-4(methyl thio) butyrate 59 mg (a hydroxyanalogue to methionine, Calcium Salt) L-Lysine Acetate USP 105 mg (Eq. to L-Lysine 75 mg) L-Threonine USP 53 mg L- Tryptophan USP 23 mg L- Histidine USP 38 mg L- Tyrosine USP 30 mg Total Nitrogen Content per tablet 36 mg Calcium Content per tablet 1.25 mmol=0.05 g Excipients q.s Colour: Titanium Dioxide IP |
| 255. | Benfotiamine Tablets 100 mg | Each Film coated tablet contains: Benfotiamine 100 mg Excipients q.s Colour: Titanium Dioxide IP |
| 256. | Biotin & Finasteride Tablets | Each uncoated Tablet Contains: Biotin IP 10 mg Finasteride IP 1 mg Excipients q.s |
| 257. | Biotin & Finasteride Tablets | Each uncoated Tablet Contains: Biotin IP 5 mg Finasteride IP 1 mg Excipients q.s |
| 258. | Biotin & Finasteride Tablets | Each uncoated Tablet Contains: Biotin IP 10 mg Finasteride IP 5 mg Excipients q.s |
| 259. | Biotin & Dutasteride Tablets | Each uncoated Tablet Contains: Biotin IP 10 mg Dutasteride IP 0. 5 mg Excipients q.s |
| 260. | Biotin Tablets USP 5 mg | Each film coated tablet contains: Biotin USP 5 mg Excipients q.s Colour: Titanium dioxide IP |
| 262 | Azithromycin Tablets IP 500 mg | Each Film Coated Tablet Contains : Azithromycin IP (as dihydrate) Equivalent to Anhydrous Azithromycin Excipients 500 mg q.s. Colour : Titanium Dioxide IP |
| 263 | Deflazacort Tablets 6 mg | Each uncoated Tablet Contains : Deflazacort Excipients 6 mg q.s |
| 264 | Deflazacort Tablets 12 mg | Each uncoated Tablet Contains : Deflazacort Excipients 12 mg q.s |
| 265. | Fluconazole Tablets IP 200 mg | Each Film Coated Tablet Contains : Fluconazole IP Excipients Colour : Titanium Dioxide IP 200 mg q.s |
| 266. | Fexofenadine Hydrochloride Tablets IP 120 mg | Each Film Coated Tablet Contains : Fexofenadine Hydrochloride IP Excipients Colour: Yellow Iron Oxide, Red Iron Oxide & Titanium Dioxide IP 120 mg q.s |
| 267. | Fexofenadine Hydrochloride Tablets IP 180 mg | Each Film Coated Tablet Contains : Fexofenadine Hydrochloride IP Excipients Colour : Yellow Iron Oxide, Red Iron Oxide & Titanium Dioxide IP 180 mg q.s |
| 268. | Ketoconazole Tablets IP 200 mg | Each uncoated Tablet Contains : Ketoconazole IP Excipients q.s200 mg |
| 269. | Levocetirizine Dihydrochloride Tablets IP 10 mg | Each Film Coated Tablet Contains : LevocetirizineDihydrochloride IP Excipients Color: Titanium Dioxide IP 10 mg q.s. |
| 270. | Montelukast Sodium and Levocetirizine HydrochlorideTablets IP | Each Film Coated Tablet Contains : Levocetirizine Dihydrochloride IP Montelukast Sodium IP Equivalent to Montelukast Excipients Colour : Titanium Dioxide IP 5 mg 10 mg q.s. |
| 271. | Levocetirizine Dihydrochloride Tablets IP 5 mg | Each Film Coated Tablet Contains : Levocetirizine dihydrochloride IP 5 mg Excipients q.s. Color: Titanium Dioxide IP |
| 272. | Methylprednisolone Tablets IP 8 mg | Each Uncoated Tablet Contains : Methylprednisolone IP 8 mg Excipients q.s. |
| 273. | Methylprednisolone Tablets IP 16 mg | Each Uncoated Tablet Contains : Methylprednisolone IP 16 mg Excipients q.s. |
| 274. | Trioxsalen Tablets USP 25mg | Each Film Coated Tablet Contains : Trioxsalen USP 25 mg Excipients q.s. Colour : Titanium Dioxide I.P |
| 275. | Tranexamic Acid (SR) Tablets 500mg | Each Film Coated Sustained Release Tablet Contains : Tranexamic Acid IP 500 mg Excipients q.s. Colours : Erythrosine & Titanium Dioxide IP |
| 276. | Tranexamic Acid & Pine Bark Extract Tablets | Each Film Coated Tablet Contains Tranexamic Acid IP 250 mg Pine Bark Extract 50 mg Excipients q.s. Colour : Red Oxide of Iron |
| 277. | Terbinafine Hydrochloride Tablets IP 250mg | Each Film Coated Tablet Contains : Terbinafine Hydrochloride IP Equivalent to Terbinafine 250 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 278. | Terbinafine Hydrochloride Tablets IP 500mg | Each Film Coated Tablet Contains : Terbinafine Hydrochloride IP Equivalent to Terbinafine 500 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 279. | Zinc Sulfate Monohydrate Tablets BP | Each film coated Tablet Contains : Zinc Sulfate Monohydrate IP 150 mg Equivalent to Elemental Zinc 54.6 mg Excipients q.s. Colour : Titanium Dioxide IP |
| 280 | Acebrophylline(SR), Montelukast And Desloratadine Tablets | Each Film Coated Tablet Contains: Acebrophylline 200 mg (As Sustained Release) Monotelukast Sodium IP Equivalent to Montelukast 10 mg Desloratadine BP 5 mg Excipients q.s. Colour: Sunset Yellow |
| 281 | Acebrophylline And N-Acetylcysteine Tablets | Each Film Coated Tablet Contains: Acebrophylline N-Acetylcysteine BP Excipients Colour: Titanium Dioxide 100 mg 600 mg q.s. |
| 282 | Acotiamide Tablets 100 mg | Each Film Coated Tablet Contains: Acotiamide Hydrochloride Hydrate 100 mg Excipients q.s. Colour: Yellow Iron oxide and Titanium Dioxide IP |
| 283 | Acotiamide Hydrochloride Hydrate SR Tablets 300mg | Each Film Coated Tablet Contains: Acotiamide Hydrochloride Hydrate 300 mg Excipients q.s. Colour: Yellow Iron Oxide and Titanium Dioxide IP |
| 284 | Alfuzosin And Dutasteride Tablets | Each Film Coated Tablet Contains: Alfuzosin Hydrochloride IP (as Enteric Coated) Dutasteride IP Excipients 10 mg 0.5 mg q.s. |
| 285 | Amlodipine And Perindopril Tablets | Each Film Coated Tablet Contains: Amlodipine Besylate IP Equivalent to Amlodipine Perindopril Erbumine IP Excipients 5mg 4mg q.s. |
| 286 | Apixaban Tablets 2.5mg | Each Film Coated Tablet Contains: Apixaban Excipients Colours: Titanium Dioxide IP and Iron Oxide Yellow 2.5mg q.s |
| 287 | Apixaban Tablets 5mg | Each Film Coated Tablet Contains: Apixaban Excipients Colours: Titanium Dioxide IP and Iron Oxide Yellow 5mg q.s |
| 288 | Azilsartan Tablets 80mg | Each Film Coated Tablet Contains: Azilsartan Kamedoxomil Equivalent to Azilsartan medoxomil Excipients Colour: Titanium Dioxide IP 80 mg q.s. |
| 289 | Benidipine Hydrochloride Tablets 4mg | Each Film Coated Tablet Contains: Benidipine Hydrochloride Excipients Colour: Titanium Dioxide IP 4mg q.s |
| 290 | Telmisartan and Benidipine Hydrochloride Tablets | Each Film Coated Tablet Contains: Benidipine Hydrochloride 4 mg Telmisartan IP 40 mg Excipients q.s Colour: Titanium Dioxide IP |
| 291 | Benidipine Hydrochloride Tablets 8 mg | Each Film Coated Tablet Contains: Benidipine Hydrochloride 8 mg Excipients q.s Colour: Titanium Dioxide IP |
| 292 | Bisoprolol Fumarate and Amlodipine Besylate Tablets | Each Film Coated Tablet Contains: Bisoprolol Fumarate IP 2.5 mg Amlodipine Besylate IP Equivalent to Amlodipine 5 mg Excipients q.s. Colours: Erythrosine lake and indigo carmine lake |
| 293 | Bisoprolol Fumarate and Amlodipine Besylate Tabelts | Each Film Coated Tablet Contains: Bisoprolol Fumarate IP 5mg Amlodipine Besylate IP Equivalent To Amlodipine 5mg Excipients q.s. Colours: Titanium Dioxide IP |
| 294 | Brivaracetam Tablets IP 50mg | Each Film Coated Tablet Contains: Brivaracetam IP 50mg Excipients q.s. Colours : Red Oxide of Iron, Yellow Oxide of Iron and Titanium Dioxide IP |
| 295 | Cilnidipine Tablets IP 10 mg | Each Film Coated Tablet Contains: Cilnidipine IP 10 mg Excipients q.s Colour: Titanium Dioxide IP |
| 296 | Cilnidipine Tablets IP 20 mg | Each Film Coated Tablet Contains: Cilnidipine IP 20 mg Excipients q.s Colour: Titanium Dioxide IP |
| 297. | Cilnidipine Tablets IP 5mg | Each Film Coated Tablet Contains: Cilnidipine IP 5mg Excipients q.s Colour: Titanium Dioxide IP |
| 298. | Dapagliflozin Tablets 10mg | Each Film Coated Tablet Contains: Dapagliflozin Propanediol Monohydrate Equivalent to Dapagliflozin 10 mg Excipients q.s. Colours: Yellow Oxide of Iron and Titanium Dioxide IP |
| 299. | Dapagliflozin Tablets 5mg | Each Film Coated Tablet Contains: Dapagliflozin Propanediol Monohydrate Equivalent to Dapagliflozin 5 mg Excipients q.s. Colours: Yellow Oxide of Iron and Titanium Dioxide IP |
| 300. | Dapagliflozin and Metformin HCl Extended Release Tablets | Each Film Coated Tablet Contains: Dapagliflozin Propanediol Monohydrate Equivalent To Dapagliflozin 10mg Metformin Hydrochloride IP 500 mg (Extended Release) Colours: Titanium Dioxide IP and Ferric Oxide Red USP NF |
| 301. | Darifenacin Hydrobromide Prolonged-Release Tablets IP 7.5mg | Each Film Coated Prolonged Release Tablet Contains: Darifenacin Hydrobromide IP Equivalent to Darifenacin 7.5 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 302. | Diacerein and Aceclofenac Tablets | Each Film Coated Tablet Contains: Diacerein IP 50mg Aceclofenac IP 100mg Excipients q.s Colour : Titanium Dioxide IP |
| 303. | Diacerein Tablets 50mg | Each Film Coated Tablet Contains: Diacerein IP 50mg Excipients q.s Colour : Titanium Dioxide IP |
| 304. | Donepezil HCl Tablets IP 5mg | Each Film Coated Tablet Contains: Donepezil Hydrochloride IP 5mg Excipients q.s Colour: Titanium Dioxide IP |
| 305. | Donepezil HCl Tablets IP 10mg | Each Film Coated Tablet Contains: Donepezil Hydrochloride IP 10 mg Excipients q.s Colour: Titanium Dioxide IP |
| 306. | Epalrestat Tablets IP 150 mg | Each Film Coated Tablet Contains: Epalrestat IP 150 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 307. | Epalrestat Tablets 50 mg | Each Film Coated Tablet Contains: Epalrestat IP 50mg Excipients q.s. Colour: Lake Sunset Yellow, Ferric Oxide Red NF and Titanium Dioxide IP |
| 308. | Etoricoxib and Thiocolchicoside Tablets | Each Film Coated Tablet Contains: Etoricoxib IP 60mg Thiocolchicoside IP 4mg Excipients q.s. Colour: Tartrazine |
| 309. | Etodolac Tablets IP 400 mg | Each Film Coated Prolonged Release Tablet Contains: Etodolac IP 400mg Excipients q.s. Colour: Ferric Oxide Red USP-NF |
| 310. | Etoricoxib and Thiocolchicoside Tablets | Each Film Coated Tablet Contains: Etoricoxib IP 60mg Thiocolchicoside IP 8 mg Excipients q.s. Colour: Tartrazine |
| 311. | Febuxostat Tablets 40mg | Each Film coated Tablet Contains: Febuxostat 40mg Excipients q.s Colour: Ferric Oxide Yellow and Titanium Dioxide IP |
| 312. | Febuxostat Tablets 80mg | Each Film coated Tablet Contains: Febuxostat 80mg Excipients q.s Colour: Ferric Oxide Yellow and Titanium Dioxide IP |
| 313. | Fenofibrate Tablets IP 145mg | Each Film Coated Tablet Contains: Fenofibrate IP 145mg Excipients q.s Colour: Red Oxide of Iron and Titanium Dioxide IP |
| 314. | Gabapentin and Nortriptyline Tablets | Each Film Coated Tablet Contains: Gabapentin IP 100 mg Nortriptyline Hydrochloride IP Equivalent to Nortriptyline 5 mg Excipients q.s Colour: Titanium Dioxide IP |
| 315. | Gabapentin and Nortriptyline Tablets | Each Film Coated Tablet Contains: Gabapentin IP 200 mg Nortriptyline Hydrochloride IP Equivalent to Nortriptyline 10mg Excipients q.s Colour: Titanium Dioxide IP |
| 316. | Gabapentin and Nortriptyline Tablets | Each Film Coated Tablet Contains: Gabapentin IP 400mg Nortriptyline Hydrochloride IP Equivalent to Nortriptyline 10mg Excipients q.s Colour: Titanium Dioxide IP |
| 317. | Glimepiride Tablets IP 0.5mg | Each Uncoated Tablet Contains: Glimepiride IP Excipients Colour: Yellow Oxide of Iron 0.5 mg q.s |
| 318. | Ibandronic Acid Tablets 150mg | Each Film Coated Tablet Contains : Ibandronate sodium monohydrate eq. to Ibandronic acid Excipients 150 mg q.s |
| 319. | Levetiracetam Tablets IP 500mg | Each Film Coated Tablet Contains: Levetiracetam IP Excipients Colour: Yellow Oxide of Iron and Titanium Dioxide IP 500mg q.s |
| 320. | Levetiracetam Tablets IP 750mg | Each Film Coated Tablet Contains : Levetiracetam IP Excipients Colour: Yellow Oxide of Iron and Titanium Dioxide IP 750mg q.s |
| 321. | Linagliptin Tablets 2.5mg | Each Film Coated Tablet Contains: Linagliptin Excipients Colours: Titanium Dioxide IP, Red Oxide of Iron 2.5mg q.s |
| 322. | Linagliptin and Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: Linagliptin Metformin Hydrochloride IP Excipients Colours: Titanium Dioxide IP, Iron Oxide Yellow 2.5mg 1000 mg q.s. |
| 323. | Linagliptin and Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: Linagliptin Metformin Hydrochloride IP Excipients Colours: Titanium Dioxide IP, Iron Oxide Yellow 2.5mg 500 mg q.s. |
| 324. | Linagliptin Tablets | Each Film Coated Tablet Contains: Linagliptin Excipients Colours: Titanium Dioxide IP, Red oxide of Iron 5mg q.s |
| 325. | Mebeverine HCl Tablets IP 200mg | Each Film Coated Tablet Contains: Mebeverine Hydrochloride IP Excipients Colour: Yellow Oxide of Iron and Titanium Dioxide IP 200mg q.s |
| 326. | Mesalamine Prolonged Release Tablets IP 400 mg | Each Prolonged Release Tablet Contains: Mesalamine IP Excipients Colour: Red Oxide of Iron 400mg q.s |
| 327. | Metoprolol Succinate Extended Release Tablets IP 25 mg | Each Film Coated Extended Release Tablet Contains: Metoprolol Succinate IP 23.75 mg Equivalent to Metoprolol Tartrate 25mg Excipients q.s Colour: Titanium Dioxide IP |
| 328. | Metoprolol Succinate Extended Release Tablets IP 50 mg | Each Film Coated Extended Release Tablet Contains: Metoprolol Succinate IP 47.5mg Equivalent to Metoprolol Tartrate 50mg Excipients q.s Colour: Titanium Dioxide IP |
| 329. | Midodrine Hydrochloride tablets USP 2.5mg | Each uncoated Tablet Contains: Midodrine Hydrochloride USP 2.5mg Excipients q.s |
| 330. | Midodrine Hydrochloride USP 5 mg | Each uncoated Tablet Contains: Midodrine Hydrochloride 5mg Excipients q.s |
| 331. | Mirabegron Extended Release Tablets 25mg | Each Film Coated Extended Release Tablets Contains : Mirabegron 25mg Excipients q.s. Colours : Ferric Oxide (Red) USP-NF, Ferric Oxide (Yellow) USP-NF and Titanium Dioxide IP |
| 332. | Mirabegron Extended Release Tablets 50mg | Each Film Coated Extended Release Tablets Contains: Mirabegron 50mg Excipients q.s. Colours: Ferric Oxide (Red) USP-NF, Ferric Oxide (Yellow) USP-NF and Titanium Dioxide IP |
| 333. | Mirabegron Extended Release 50mg and Solifenacin Succinate 5mg Tablets | Each Film Coated Tablet Contains: Mirabegron IP 50mg (As ExtendedRelease) Solifenacin Succinate IP 5mg Excipients q.s. Colours: Ferric Oxide Yellow USP-NF and Titanium Dioxide IP |
| 334. | MirtazapineTablets IP 7.5mg | Each Film Coated Tablet Contains: Mirtazapine IP 7.5mg Excipients q.s Colour : Titanium Dioxide IP |
| 335. | Montelukast and Fexofenadine Hydrochloride Tablets | Each Film Coated Tablets Contains: Montelukast Sodium IP Equivalent to Montelukast 10mg Fexofenadine Hydrochloride IP 120mg Excipients q.s Colour: Quinoline Yellow |
| 336. | Mycophenolic Acid Delayed-Release Tablets USP 360mg | Each Delayed-Release film coated Tablet Contains: Mycophenolate Sodium USP Equivalent to Mycophenolic Acid 360 mg Excipients q.s. Colours : Tartrazine, Yellow oxide of Iron and Titanium Dioxide IP |
| 337. | N-Acetylcysteine and Taurine Tablets | Each Film Coated Tablet Contains: N-Acetylcysteine USP 150mg Taurine USP 500mg Excipients q.s. Colour: Titanium Dioxide IP |
| 338. | Nebivolol Tablets IP 2.5mg | Each Uncoated Tablet Contains: Nebivolol Hydrochloride IP Equivalent To Nebivolol 2.5 mg Excipients q.s |
| 339. | Nitroglycerine Controlled Release Tablets 2.6mg | Each Uncoated Controlled Release Tablet Contains : Diluted Nitroglycerine IP Equivalent to Nitroglycerine 2.6 mg (In a Controlled Release form) Excipients q.s Colour: Erythrosine |
| 340. | Nitroglycerine Controlled ReleaseTablets 6.4mg | Each Uncoated Controlled Release Tablet Contains : Diluted Nitroglycerine IP Equivalent to Nitroglycerine 6.4mg (In a Controlled Release form) Excipients q.s Colour: Erythrosine |
| 341. | Nitrofurantoin Tablets IP 50mg | Each uncoated Tablet Contains: Nitrofurantoin IP 50mg Excipients q.s |
| 342. | Olanzapine Mouth Dissolving Tablets 2.5mg | Each Uncoated Mouth Dissolving Tablet Contains : Olanzapine IP 2.5mg Excipients q.s |
| 343. | Olanzapine Mouth Dissolving Tablets 5.0mg | Each Uncoated Mouth Dissolving Tablet Contains : Olanzapine IP 5 mg Excipients q.s |
| 344. | Olanzapine Mouth Dissolving Tablets 7.5mg | Each Uncoated Mouth Dissolving Tablet Contains : Olanzapine IP 7.5mg Excipients q.s |
| 345. | Oxcarbazepine Tablets IP 300mg | Each Film Coated Tablet Contains: Oxcarbazepine IP 300mg Excipients q.s Colour :Yellow Oxide Of Iron and Titanium Dioxide IP |
| 346. | Paroxetine Prolonged Release Tablets IP 12.5mg | Each Film Coated Prolonged-Release Tablet Contains : Paroxetine Hydrochloride IP Equivalent to Paroxetine 12.5mg Excipients q.s. Colours: Ferric Oxide Red USP-NF and Titanium Dioxide IP |
| 347. | Paroxetine Hydrochloride Tablets 25mg | Each Film Coated Prolonged-Release Tablet Contains : Paroxetine Hydrochloride IP Equivalent to Paroxetine 25mg Excipients q.s. Colours: Ferric Oxide Red USP-NF and Titanium Dioxide IP |
| 348. | Perindopril Erbumine and Indapamide Tablets | Each Uncoated Tablet Contains: Perindopril Erbumine IP 4mg Indapamide IP 1.25mg Excipients q.s. |
| 349. | Prazosin Hydrochloride Tablets IP 2.5mg | Each Uncoated Tablet Contains: Prazosin Hydrochloride IP Equivalent to Prazosin 2.5mg Excipients q.s |
| 350. | Propranolol Tablets IP 40mg | Each uncoated Tablet Contains: Propranolol Hydrochloride IP 40mg Excipients q.s |
| 351. | Prucalopride Tablets 2mg | Each Film Coated Tablet Contains: Prucalopride Succinate Equivalent to Prucalopride 2 mg Excipients q.s Colours: Red Oxide of Iron, Yellow Oxide of Iron and Titanium Dioxide IP |
| 352. | Rifaximin Tablets 550mg | Each Film Coated Tablet Contains: Rifaximin BP 550mg Excipients q.s. Colours: Sunset Yellow FCF and Titanium Dioxide IP |
| 353. | Rifaximin Tablets 400mg | Each Film Coated Tablet Contains: Rifaximin BP 400mg Excipients q.s. Colours: Sunset Yellow FCF and Titanium Dioxide IP |
| 354. | Rosuvastatin and Fenofibrate Tablets IP | Each Film Coated Tablet Contains: Rosuvastatin Calcium IP Equivalent to Rosuvastatin 10mg Fenofibrate IP 67.5 mg Excipients q.s Colour : Sunset Yellow |
| 355. | Atorvastatin Tablets IP 5 mg | Each Film Coated Tablet Contains: Atorvastatin Calcium IP Equivalent to Atorvastatin 5 mg Excipients q.s Colour: Titanium Dioxide IP |
| 356. | Rosuvastatin and Fenofibrate Tablets IP | Each Film Coated Tablet Contains: Rosuvastatin Calcium IP Equivalent to Rosuvastatin 10mg Fenofibrate IP 160 mg Excipients q.s Colour : Titanium Dioxide IP |
| 357. | Rosuvastatin and Fenofibrate Tablets IP | Each Film Coated Tablet Contains: Rosuvastatin Calcium IP Equivalent to Rosuvastatin 20mg Fenofibrate IP 160 mg Excipients q.s Colour : Titanium Dioxide IP |
| 358. | Rosuvastatin Tablets IP 20mg | Each Film Coated Tablet Contains: Rosuvastatin Calcium IP Equivalent to Rosuvastatin 20 mg Excipients q.s Colour: Ponceau-4R |
| 359. | Sacubitril/Valsartan Tablets 50mg | Each Film Coated Tablet Contains: Sacubitril and valsartan 50mg (24mg+26 mg) Excipients q.s Colours: Titanium Dioxide, Iron Oxide Red and Iron Oxide Black |
| 360. | Sacubitril/ValsartanTablets100mg | Each Film Coated Tablet Contains: Sacubitril and valsartan 100mg (49 mg+51mg) Excipients q.s Colours: Titanium Dioxide, Iron Oxide Red and Iron Oxide Black |
| 361. | Sevelamer CarbonateTablets 400mg | Each Film Coated Tablet Contains: Sevelamer Carbonate 400 mg Excipients q.s Colour: Titanium Dioxide IP |
| 362. | Sevelamer CarbonateTablets 800mg | Each Film Coated Tablet Contains: Sevelamer Carbonate 800 mg Excipients q.s Colour: Titanium Dioxide IP |
| 363. | Silodosin and DutasterideTablets | Each Film Coated Tablet Contains: Silodosin 8mg Dutasteride IP 0.5mg Excipients q.s. Colour: Titanium Dioxide IP |
| 364. | Sitagliptin Tablets IP 100mg | Each Film Coated Tablet Contains: Sitagliptin Phosphate Monohydrate IP Equivalent To Sitagliptin 100mg Excipients q.s. Colours: Red Oxide of Iron, Yellow Oxide of Iron and Titanium Dioxide IP |
| 365. | Sitagliptin Tablets IP 50mg | Each Film Coated Tablet Contains: Sitagliptin Phosphate Monohydrate IP Equivalent To Sitagliptin 50 mg Excipients q.s. Colour: Oxide of Iron, Yellow Oxide of Iron and Titanium Dioxide IP |
| 366. | Alendronate Sodium Tablets IP 70mg | Each Film Coated Tablet Contains: Sodium Alendronate Trihydrate IP Equivalent to Alendronic Acid 70mg Excipients q.s. |
| 367. | Sodium Bicarbonate Tablets USP 500mg | Each Film Coated Tablet Contains: Sodium Bicarbonate USP 500mg Excipients q.s Colour: Titanium Dioxide IP |
| 368. | Sulfasalazine Delayed Release Tablets IP 500mg | Each Delayed Release Tablet Contains: Sulfasalazine IP 500mg Excipients q.s Colour: Ferric Oxide Yellow |
| 369. | Sulfasalazine Delayed Release Tablets IP 1000mg | Each Delayed Release Tablet Contains: Sulfasalazine IP 1000 mg Excipients q.s Colour: Ferric Oxide Yellow |
| 370. | Sodium Bicarbonate Tablets USP 1000mg | Each Film Coated Tablet Contains: Sodium Bicarbonate USP 1000 mg Excipients q.s Colour: Titanium Dioxide IP |
| 371. | Telmisartan Tablets IP 40mg | Each Film Coated Tablet Contains: Telmisartan IP 40 mg Excipients q.s Colour: Titanium Dioxide IP |
| 372. | Telmisartan Tablets IP 80mg | Each Film Coated Tablet Contains: Telmisartan IP 80 mg Excipients q.s Colour: Titanium Dioxide IP |
| 373. | Telmisartan and Amlodipine Tablets IP 40mg/5 mg | Each Uncoated Tablet Contains: Telmisartan IP Amlodipine Besilate IP 40mg 5 mg q.s. Equivalent to Amlodipine Excipients Colour: Yellow Oxide of Iron |
| 374. | Telmisartan and Benidipine Hydrochloride Tablets | Each Film Coated Tablet Contains: Benidipine Hydrochloride 4mg Telmisartan IP 40mg Excipients q.s. |
| 375. | Telmisartan and Chlorthalidone Tablets | Each Film Coated Tablet Contains: Telmisartan IP 40mg Chlorthalidone IP 12.5 mg Excipients q.s Colour: Titanium Dioxide IP |
| 376. | Telmisartan (Immediate Release) and Metoprolol (Extended Release)Tablets | Each uncoated Bilayered Tablet Contains: Telmisartan IP 40 mg (In Immediate Release Form) Metoprolol SuccinateIP 23.75 mg Equivalent to Metoprolol Tartrate 25 mg (In Extended Release Form) Excipients q.s Colour: Sunset Yellow (In Metoprolol Layer) |
| 377. | Teneligliptin and Metformin Hydrochloride Sustained Release Tablets IP | Each Uncoated Bilayered Tablet Contains: Teneligliptin Hydrobromide Hydrate Equivalent to Teneligliptin 20 mg Metformin Hydrochloride IP 500 mg (As Sustained Release) Excipients q.s. Colour: Ferric Oxide Yellow USP-NF (In Teneligliptin Layer) |
| 378. | Teneligliptin and Metformin Hydrochloride Sustained Release Tablets IP | Each Uncoated Bilayered Tablet Contains: Teneligliptin Hydrobromide Hydrate IP Equivalent toTeneligliptin 20mg Metformin Hydrochloride IP 1000mg (As Sustained Release) Excipients q.s. Colours : Ferric Oxide Yellow USP-NF (In Teneligliptin Layer) |
| 379. | Teneligliptin Tablets IP 20mg | Each uncoated Tablet Contains: Teneligliptin Hydrobromide Hydrate IP Equivalent to Teneligliptin 20 mg Excipients q.s. Colour: Ferric oxide Yellow USP-NF |
| 380. | Ticagrelor Tablets IP 60mg | Each Film Coated Tablet Contains: Ticagrelor IP 60 mg Excipients q.s. Colours: Ferric oxide Black USP-NF Ferric oxide Red USP-NF and Titanium Dioxide IP |
| 381. | Ticagrelor Tablets IP 90mg | Each Film Coated Tablet Contains: Ticagrelor IP 90 mg Excipients q.s Colour: Red Oxide of Iron |
| 382. | Torsemide Tablets IP 10mg | Each Uncoated Tablet Contains: Torsemide IP 10 mg Excipients q.s |
| 383. | Torsemide Tablets IP 5mg | Each uncoated Tablet Contains: Torsemide IP 5mg Excipients q.s |
| 384. | Trimetazidine hydrochloride modified-release Tablets 35 mg | Each Film Coated modified-release Tablet Contains: Trimetazidine Dihydrochloride IP 35mg Excipients q.s Colour: Titanium Dioxide IP |
| 385. | Ursodeoxycholic Acid Tablets IP 300mg | Each Film Coated Tablet Contains: Ursodeoxycholic Acid IP 300 mg Excipients q.s Colours: Red oxide of Iron and Yellow oxide of Iron |
| 386. | Ursodeoxycholic Acid Tablets IP 450 mg | Each Film Coated Tablet Contains: Ursodeoxycholic Acid IP 450 mg Excipients q.s Colours: Red oxide of Iron and Yellow oxide of Iron |
| 387. | Vildagliptin Tablets IP 100mg | Each uncoated Tablet Contains: Vildagliptin IP 100mg Excipients q.s |
| 388. | Vildagliptin Tablets IP 50mg | Each uncoated Tablet Contains: Vildagliptin IP 50mg Excipients q.s |
| 389. | Vildagliptin and Metformin HCl Tablets IP | Each Film Coated Tablet Contains: Vildagliptin IP 50mg Metformin Hydrochloride IP 500mg Excipients q.s Colour : Red Oxide Of Iron, Yellow Oxide Of Iron and Titanium Dioxide IP |
| 390. | Vildagliptin and Metformin HCl Tablets IP | Each Film Coated Tablet Contains: Vildagliptin IP 50mg Metformin Hydrochloride IP 1000mg Excipients q.s Colour : Red Oxide Of Iron, Yellow Oxide Of Iron and Titanium Dioxide IP |
| 391. | Voglibose Mouth Dissolving Tablets 0.2mg | Each uncoated Mouth Dissolving Tablet Contains : |
| Voglibose IP Excipients | ||
| 392. | Voglibose Mouth Dissolving Tablets 0.3mg | Each uncoated Mouth Dissolving Tablet Contains: Voglibose IP Excipients |
| Fluvastatin Calcium IP Equivalent To Fluvastatin Excipients Colours: Titanium Dioxide IP 40 mg q.s | ||
| 406. | Pitavastatin Tablets 4 mg | Each Film coated tablet Contains: Pitavastatin Calcium IP Equivalent To Pitavastatin Excipients Colour : Titanium Dioxide IP 4 mg q.s. |
| 407. | Pregabalin and Nortriptyline Tablets | Each Film coated tablet contains : Pregabalin IP Nortriptyline Hydrochloride IP 75 mg 10 mg q.s Equivalent To Nortriptyline Excipients Colour: Titanium Dioxide IP |
| 408. | Rosuvastatin Tablets IP 5 mg | Each Film coated tablet contains: Rosuvastatin Calcium IP Equivalent to Rosuvastatin 5 mg Excipients q.s Colour : Ponceau-4R |
| 409. | Tamsulosin Hydrochloride Modified Release Tablets 0.4 Mg | Each Film coated Modified Release tablet con Tamsulosin Hydrochloride IP tains 0.4 mg q.s. e IP (As Modified Release) Excipients Colour : Red oxide of Iron and Titanium Dioxid |
| 410. | Tamsulosin Hydrochloride and Dutasteride Tablets | Each Film coated tablet contains Tamsulosin Hydrochloride IP 0.4 mg 0.5 mg q.s.Dutasteride IP Excipients Colour : Titanium Dioxide IP |
| 411. | Entecavir Tablets IP 0.5 mg | Each Film coated tablet contains : Entecavir IP (As Monohydrate)0.5 mg Excipients Colour : Titanium Dioxide IP q.s |
| 412. | Entecavir Tablets IP 1.0mg | Each film coated tablet contains : Entecavir IP (As Monohydrate) Excipients Colour : Titanium Dioxide IP |
| 413. | Atorvastatin Tablets IP 10mg | Each Film coated tablet contains: Atorvastatin Calcium IP Equivalent To Atorvastatin 10 mg Excipients q.s. Colour : Titanium Dioxide IP |
| 414. | Atorvastatin Tablets IP 20 mg | Each Film coated tablet contains: Atorvastatin Calcium IP Equivalent To Atorvastatin 20mg Excipients q.s. Colour : Titanium Dioxide IP 1.0mg q.s |
| 415. | Nateglinide, Metformin Hydrochloride and Voglibose Tablets | Each Film coated tablet contains : Nateglinide USP Metformin Hydrochloride IP Voglibose IP 60 mg 500 mg 0.2 mg q.s. Excipients Colour: Sunset Yellow |
| 416. | Nateglinide, Metformin Hydrochloride and Voglibose Tablets | Each Film coated tablet contains : Nateglinide USP 60 mg |
| Metformin Hydrochloride IP 500 mg Voglibose IP 0.2 mg Excipients Colour: Sunset Yellow q.s. | ||
| 417. | Benidipine Hydrochloride and Chlorthalidone Tablets | Each Film Coated Tablet Contains : Benidipine Hydrochloride 4 mg Chlorthalidone IP 12.5mg Excipientsq.s. Colour: Titanium Dioxide IP |
| 418. | Bisoprolol Fumarate and Amlodipine Besylate Tablets | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP 5mg Amlodipine Besylate IP Equivalent To Amlodipine Base 2.5mg Excipients q.s. Colours : Titanium Dioxide IP |
| 419. | Sitagliptin Phosphate Monohydrate and Metformin Hydrochloride Tablets | Each Film coated tablet contains : Sitagliptin phosphate monohydrate IP Equivalent to sitagliptin 50 mg Metformin hydrochloride IP (as extended-release) 850 mg Excipients q.s Colours : Titanium dioxide IP, Indigo Carmine and Aluminium lake |
| 420. | Repaglinide Tablets IP 1 mg | Each uncoated tablet contains : Repaglinide IP 1 mg Excipients q.s Colour : Yellow Oxide Of Iron |
| 421. | Tenofovir Alafenamide Tablets IP 25 mg | Each Film Coated Tablet Contains : Tenofovir Alafenamide Fumarate IP 25 mg q.s.Equivalent to Tenofovir Alafenamide Excipients Colour : Titanium Dioxide IP |
| 422. | Melatonin Tablets 5 mg | Each uncoated Tablet contains: Melatonin BP 5 mg Excipients q.s. |
| 423. | Diclofenac Potassium And Metaxalone Tablets | Each uncoated Tablet contains: Diclofenac Potassium IP 50 mg Metaxalone 400 mg Excipients q.s. Colour ferric oxide yellow USPNF |
| 424. | Tolperisone Hydrochloride Tablets 150 mg | Each Film Coated Tablet Contains Tolperisone Hydrochloride 150 mg Excipients q.s. Colour : Titanium Dioxide IP |
| 425. | Prucalopride Tablets 1 mg | Each Film Coated Tablet Contains: Prucalopride Succinate Equivalent to Prucalopride 1 mg Excipients q.s Colours: Red Oxide of Iron, Yellow Oxide of Iron and Titanium Dioxide IP |
| 426. | Tofacitinib Extended Release Tablets 11 mg | Each Film coated extended release tablet Contains : Tofacitinib Citrate IP Equivalent to Tofacitinib 11 mg Excipients q.s Colour : Titanium Dioxide IP and Ferric Oxide (Red) USPNF |
| 427. | Sertraline Tablets IP 50 mg | Each Film coated tablet Contains : Sertraline Hydrochloride IP Equivalent to Sertraline 50 mg Excipients q.s Colour : Yellow oxide of Iron ,Titanium Dioxide IP |
| 428. | Sertraline Tablets IP 25 mg | Each Film coated tablet Contains : Sertraline Hydrochloride IP Equivalent to Sertraline 25 mg Excipients q.s Colour : Yellow oxide of Iron ,Titanium Dioxide IP |
| 429. | Telmisartan Tablets IP 20 mg | Each Film Coated Tablet Contains: Telmisartan IP 20 mg Excipients q.s Colour: Titanium Dioxide IP |
| 430. | Telmisartan and Hydrochlorothiazide Tablets IP 80mg/12.5mg | Each Film coated bi-layered Tablet Contains : Telmisartan IP 80 mg Hydrochlorothiazide IP 12.5mg Excipients q.s. Colour: sunset yellow IP |
| 431. | Telmisartan and Amlodipine Tablets IP 80mg /5mg | Each Uncoated Tablet Contains: Telmisartan IP 80mg Amlodipine Besilate IP Equivalent to Amlodipine 5 mg Excipients q.s. Colour: Yellow Oxide of Iron |
| 432. | Cilnidipine, Telmisartan and Chlorthalidone Tablets | Each Film Coated Tablet Contains: Cilnidipine IP 10 mg Telmisartan IP 40 mg Chlorthalidone IP 6.25 mg Excipients q.s Colour: Iron oxide of yellow and Titanium Dioxide IP |
| 433. | Cilnidipine, Telmisartan and Chlorthalidone Tablets | Each Film Coated Tablet Contains: Cilnidipine IP 10 mg Telmisartan IP 40 mg Chlorthalidone IP 12.5 mg Excipients q.s Colour: Iron oxide of yellow and Titanium Dioxide IP |
| 434. | Telmisartan and Cilnidipine Tablets | Each Film Coated Tablet Contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Excipients q.s. Colour: Red oxide of iron |
| 435. | Mesalamine Prolonged Release Tablets IP 1200 mg | Each Prolonged Release Tablet Contains: Mesalamine IP 1200 mg Excipients q.s Colour: Red Oxide of Iron |
| 436. | Obeticholic Acid Tablets 5 mg | Each Film Coated Tablet Contains: Obeticholic Acid 5 mg Excipients q.s Colour: Iron oxide of yellow and Titanium dioxide IP |
| 437. | Obeticholic Acid Tablets 10 mg | Each Film Coated Tablet Contains: Obeticholic Acid 10 mg Excipients q.s Colour: Iron oxide of yellow and Titanium dioxide IP |